HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ken-Ichiro Inoue Selected Research

Ken-Ichiro Inoue Research Topics

Disease

22Inflammation (Inflammations)
01/2021 - 06/2004
14Pneumonia (Pneumonitis)
12/2012 - 05/2006
8Asthma (Bronchial Asthma)
07/2017 - 01/2005
5Lung Injury
04/2011 - 04/2005
3Atopic Dermatitis (Atopic Eczema)
07/2017 - 09/2008
3Hypersensitivity (Allergy)
07/2017 - 03/2007
3Disseminated Intravascular Coagulation
11/2008 - 03/2005
3Pancreatitis
11/2008 - 03/2005
3Shock
11/2008 - 03/2005
3Acute Lung Injury
11/2008 - 04/2005
2Respiratory Tract Diseases (Respiratory Tract Disease)
08/2021 - 03/2007
2Disease Progression
01/2020 - 03/2010
2Pulmonary Emphysema
08/2010 - 03/2010
2Hyperplasia
04/2010 - 08/2007
2Infections
03/2007 - 11/2006
1COVID-19
12/2020
1Edema (Dropsy)
02/2018
1Neoplasms (Cancer)
09/2013
1Rhinitis
06/2013
1Allergic Rhinitis
06/2013
1Emphysema
03/2010
1Skin Diseases (Skin Disease)
03/2009
1Respiratory Hypersensitivity
08/2007
1Non-alcoholic Fatty Liver Disease
01/2007
1Diabetes Mellitus
01/2007
1Lung Diseases (Lung Disease)
11/2006
1Vascular Diseases (Vascular Disease)
11/2006
1Pulmonary Edema
09/2006
1Body Weight (Weight, Body)
05/2006
1Colitis
08/2004
1Acute-Phase Reaction
08/2004
1Sepsis (Septicemia)
06/2004
1Rheumatoid Arthritis
07/2003

Drug/Important Bio-Agent (IBA)

10Vehicle Emissions (Emissions, Vehicle)IBA
08/2021 - 05/2006
10CytokinesIBA
04/2011 - 08/2004
10LipopolysaccharidesIBA
02/2011 - 02/2005
8AllergensIBA
02/2018 - 08/2005
81-(2-(dodecyloxy)ethyl)pyrrolidine hydrochloride (DEP)IBA
01/2009 - 05/2006
7Interleukin-6 (Interleukin 6)IBA
01/2021 - 08/2004
6Particulate MatterIBA
09/2013 - 09/2006
6EndotoxinsIBA
02/2011 - 04/2005
5ChemokinesIBA
04/2011 - 04/2005
4Chemotactic FactorsIBA
12/2012 - 09/2006
4urinastatin (MR 20)IBA
11/2008 - 03/2005
3Organic Chemicals (Chemicals, Organic)IBA
07/2017 - 01/2007
3phthalic acid (phthalate)IBA
07/2017 - 09/2008
3OvalbuminIBA
09/2013 - 01/2005
3SootIBA
04/2011 - 09/2006
3Proteins (Proteins, Gene)FDA Link
04/2010 - 09/2008
3Pharmaceutical PreparationsIBA
11/2008 - 03/2005
3Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA
11/2008 - 03/2005
3AntigensIBA
09/2008 - 01/2005
2Protease Inhibitors (Protease Inhibitor)IBA
12/2020 - 01/2020
2SandIBA
07/2017 - 09/2007
2Diethylhexyl Phthalate (DEHP)IBA
06/2013 - 09/2008
2Pancreatic Elastase (Elastase)IBA
04/2011 - 03/2010
2Carbon Nanotubes (Carbon Nanotube)IBA
04/2010 - 12/2008
2Interleukin-1beta (Interleukin 1 beta)IBA
03/2010 - 09/2006
2CarbonIBA
12/2008 - 09/2006
2Leukocyte Elastase (Neutrophil Elastase)IBA
11/2008 - 03/2005
2NaphthoquinonesIBA
04/2008 - 08/2007
2Interleukin-13IBA
08/2007 - 08/2005
2InterleukinsIBA
01/2007 - 08/2005
1Environmental Pollutants (Pollutants, Environmental)IBA
07/2017
1PlasticizersIBA
07/2017
1PlasticsIBA
07/2017
1Air Pollutants (Pollutants, Air)IBA
07/2017
1EstersIBA
07/2017
1OzoneIBA
12/2012
1PeroxiredoxinsIBA
12/2012
1LipidsIBA
12/2012
1Immunoglobulin E (IgE)IBA
04/2010
1Immunoglobulin G (IgG)IBA
04/2010
1Cholinergic Agents (Cholinergics)IBA
03/2010
1Methacholine Chloride (Methacholine)FDA Link
03/2010
1Biomarkers (Surrogate Marker)IBA
03/2010
1Alkaline PhosphataseIBA
03/2010
1L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
03/2010
1titanium dioxide (Titania)FDA Link
03/2009
1Dacarbazine (DIC)FDA LinkGeneric
11/2008
1Immunoglobulins (Immunoglobulin)IBA
09/2008
1indium-bleomycinIBA
05/2008
1KaolinIBA
09/2007
1beta-GlucansIBA
09/2007
1Interleukin-5 (Interleukin 5)IBA
03/2007
1Toll-Like Receptors (Toll-Like Receptor)IBA
01/2007
1Fibrinogen (Factor I)FDA Link
11/2006
1E-SelectinIBA
11/2006
1Toll-Like Receptor 4IBA
05/2006
1Rosmarinic AcidIBA
08/2005
1Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
04/2005
1MetallothioneinIBA
01/2005
1sodium sulfate (sodium bisulfate)FDA LinkGeneric
08/2004
1Dextrans (Dextran)FDA Link
08/2004
1Drinking WaterIBA
08/2004
1Dextran SulfateIBA
08/2004
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
06/2004
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
07/2003

Therapy/Procedure

1Aftercare (After-Treatment)
12/2008